Effect of transcutaneous immunization with co-administered antigen and cholera toxin on systemic and mucosal antibody responses in sheep.
Direct application of antigens to skin together with an adjuvant, a procedure called transcutaneous immunization (TCI), can induce systemic immune responses in mice, humans, cats and dogs. In previous studies we found that cholera toxin (CT) applied topically on unbroken skin induces systemic antibody and lymphocyte proliferative responses in sheep. The current study examined whether concurrent administration of CT and tetanus toxoid (TT) delivered transcutaneously could induce specific antibody responses to both antigens in sheep. Antibodies to both TT and CT were induced by TCI although antibody titres in serum to TT were higher in sheep receiving TT plus alum by intramuscular injection (n=5) than TT plus CT by TCI (n=5). The ratio of IgG1/IgG2 antibody to TT in serum was near unity, and the route of immunization, TCI versus injection, did not influence this ratio. In contrast, the ratio of IgG1/IgG2 antibody differed significantly between the two antigens, TT and CT, delivered by TCI, with a higher proportion of IgG1 antibody in serum to CT than TT. Antibody to TT was detected in lung washes from TCI and injection groups, with IgG1 predominating over IgG2 in both groups. IgA antibodies to CT and TT were detected in sera of CT and TT-immunized groups respectively but in lung washes IgA antibody to TT was detected only in the injection group. Results show that TCI induced systemic antibody responses to CT and the co-administered antigen TT, whereas no evidence was obtained for mucosal IgA responses following TCI.
Chen
D
D
CSIRO Livestock Industries, Pastoral Research Laboratory, Locked Bag 1, Post Office, Armidale, NSW 2350, Australia.
Colditz
I G
IG
Glenn
G M
GM
Tsonis
C G
CG
D000279:Administration, Cutaneous; D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis / Q000097:blood; D000914:Antibodies, Viral / Q000096:biosynthesis / Q000097:blood; D002771:Cholera / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D002772:Cholera Toxin / Q000008:administration & dosage / Q000276:immunology* / Q000494:pharmacology; D018928:Immunity, Mucosal / Q000276:immunology; D007114:Immunization / Q000379:methods / Q000662:veterinary*; D007074:Immunoglobulin G / Q000096:biosynthesis / Q000097:blood; D008297:Male; D011897:Random Allocation; D012756:Sheep; D012757:Sheep Diseases / Q000276:immunology* / Q000517:prevention & control / Q000821:virology; D013742:Tetanus / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D013745:Tetanus Toxoid / Q000008:administration & dosage / Q000276:immunology* / Q000494:pharmacology
D000907:Antibodies, Bacterial; D000914:Antibodies, Viral; D007074:Immunoglobulin G; D013745:Tetanus Toxoid; D002772:Cholera Toxin